AtriCure amends 8-K to add director Shlomi Nachman to two board committees

AtriCure, Inc.

Shlomi Nachman elected to Board on Jan 4, 2024, as previously reported.
Effective Feb 22, 2024, Nachman appointed to Strategy Committee and Compliance, Quality and Risk Committee.
Amendment filed to disclose committee assignments not included in original 8-K.

item 5.02 item 9.01

AtriCure, Inc. filing history →

Source: SEC EDGAR

accession 0001323885-24-000020

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.